- Fetal Upturned Nose
- IgA Nephropathy in Pregnancy
- Umbilical vein varix
- Timing of Cranial Markers in Open NTD
- Real world experience Open Neural tube defect and Brain Signs
- Real world experience First Trimester Megacystis – Management
- Real world experience Fetal Megacystis
- Abnormal facial profile
- Azygous Vein & ARSA
- Blakes Pouch Cyst
- Absent nasal bone (ANB)
- Choroid plexus cysts
- Chronic placental abruption
- Fetal Alcohol Syndrome
- Placenta-First Risk Stratification
- AVSD
- Blakes Pouch Cyst
- Confined Placental Mosaicism
- Echogenic Bowel
- Fetal Anemia
- Fetal Club Foot
- Fetal Mild Micromelia
- Hypochondroplasia – Mild Micromelia
- Hypoplastic Nasal Bone
- IgM IgG IgG Avidity
- Increased Nuchal Translucency
- Isotretinoin in Pregnancy
- Partial agenesis of corpus callosum
- PGT A
- PGT-A Mosaicism to CPM
- Placenta First - CPM
- Radiation exposure during pregnancy
- Real world Chorionic bump experience
- Real world Fetal Isotretinoin exposure
- Real world Increased Nuchal Translucency & Genetic RISK
- Real world Renal Pyelectasis
- Real world Transient NT & Cystic Hygroma
- Real world Transient NT
- Renal Pyelectasis or Extra Renal Pelvis
- Right And Double Aortic Arch
- Short Femur Length Foot FL ratio
- Y Microdeletion
- CCAM CPAM
- Coffin–Siris syndrome
- Congenital CMV Infection
- Increased NT and Localized CHAOS
- Indomethacin and Reduction for AFI
- Atrioventricular septal defect (AVSD)
- Choledochal cyst & Cystic biliary atresia
- Duodenal Atresia
- Fetal atrial bigeminy
- Fetal Dilated stomach
- Mutation Types in DMD
- Risk of rubella in nonimmune pregnant woman
- Salt-losing nephropathy
- Syndromic Cystic biliary atresia
- TGA DORV TOF CCTGA
- Unilateral echogenic kidney with polyhydramnios
- Unilateral renal agenesis, Ectopic, Cross fused kidney
Azoospermia - Genetic causes
Chromosomal abnormalities (non-AZF)
- Klinefelter syndrome (47,XXY)
Most common cause of non-obstructive azoospermia.
Mosaic forms (46,XY/47,XXY) may have focal spermatogenesis. - Structural rearrangements
Balanced translocations, inversions, ring chromosomes.
Often severe spermatogenic arrest.
Monogenic causes of non-obstructive azoospermia
These affect meiosis, germ cell development, or Sertoli cell function.
Obstructive azoospermia with intact spermatogenesis
Y-microdeletion testing - normal.
- CFTR mutations
- Congenital bilateral absence of vas deferens (CBAVD)
- Testes normal size, normal FSH, low semen volume, acidic pH
- ADGRG2 mutations (X-linked)
- CFTR-negative CBAVD
Disorders of sex development spectrum (mild)
- May present only with infertility.
- Partial gonadal dysgenesis
- NR5A1, WT1 variants
Mitochondrial and spermiogenesis-specific genes
- Severe oligozoospermia or azoospermic.
- DNAH genes
- SPATA genes
- TEX14
Step 1: Confirm true azoospermia
- Two semen analyses with centrifugation
- Exclude cryptozoospermia
Step 2: Hormonal profile
- FSH, LH, testosterone, prolactin
- High FSH + small testes → non-obstructive pattern
- Normal FSH + normal testes → suspect obstruction
Step 3: Karyotype (essential)
- Detects 47,XXY and structural abnormalities
- Should be done in all azoospermic men
Step 4: Targeted gene testing
If obstructive pattern
- CFTR mutation analysis (including 5T variant)
- ADGRG2 if CFTR negative and CBAVD suspected
If non-obstructive pattern
- Gene panel or WES focusing on spermatogenesis genes (TEX11, NR5A1, DMRT1, meiosis genes)
Step 5: Imaging
- Scrotal ultrasound: testicular volume, microlithiasis
- TRUS if ejaculatory duct obstruction suspected
Step 6: Testicular biopsy / micro-TESE
- Diagnostic and therapeutic
- Histology guides prognosis
- Sertoli cell-only
- Maturation arrest
- Hypospermatogenesis
Y-chromosome microdeletion
Submicroscopic deletions on Yq11, involving regions essential for spermatogenesis. They are not visible on karyotype and require PCR or molecular testing.
These deletions affect the AZF regions (Azoospermia Factor):
- AZFa
- AZFb
- AZFc
- Sometimes combined (AZFbc, AZFabc)
They are among the commonest known genetic causes of non-obstructive azoospermia (NOA).
Epidemiology
- Present in:
- ~10–15% of men with non-obstructive azoospermia
- ~5–7% with severe oligozoospermia
- Rare in fertile men
- Risk increases as sperm count decreases
The type of AZF deletion alone determines prognosis and management.
Hormones, ultrasound, and age cannot override this.
AZF Types, Meaning, and Counseling
| AZF region | Key genes (examples) | Typical testicular histology | Chance of sperm retrieval | Management advice | Counseling message |
|---|---|---|---|---|---|
| AZFa | USP9Y, DDX3Y | Sertoli cell–only | ~0% | ❌ Do not attempt TESE | “This deletion prevents sperm cells from forming. Surgical retrieval is not helpful.” |
| AZFb | RBMY1, EIF1AY | Complete maturation arrest | <5% | ❌ TESE generally futile | “Sperm development stops early. Finding usable sperm is extremely unlikely.” |
| AZFc | DAZ, CDY1, BPY2 | Variable: focal spermatogenesis possible | 40–70% | ✅ micro-TESE recommended | “Some sperm production may be present in small areas. Surgery may succeed.” |
| AZFbc / AZFabc | Combined loss | Severe germ cell failure | ~0% | ❌ Do not attempt TESE | “This is equivalent to AZFb or worse in outcome.” |
Typical clinical pattern
- Non-obstructive azoospermia
- FSH often elevated
- Testes may be small or normal
- No effect on sexual function or general health
What AZF deletions do NOT cause
- No birth defects
- No intellectual disability
- No hormonal syndromes
- No increased cancer risk
This is isolated testicular failure, not a systemic disorder.
Inheritance and offspring risk
- All male offspring will inherit the same AZF deletion
- Sons will likely face infertility
- Female offspring are unaffected
- PGT-A does not prevent transmission
- This is a fertility issue, not a childhood disease
Common misunderstandings to clarify
- AZFc ≠ hopeless
- Yq12 deletion ≠ AZF deletion
- Normal testosterone ≠ normal sperm production
- TESE should not be attempted in AZFa or AZFb
Practical counseling line
“The Y-chromosome finding explains why sperm are absent. The exact region involved tells us whether surgery can help. In your case, our plan is based on the AZF type, not guesswork.”
Bottom line
- Always identify the AZF subtype
- AZFa / AZFb → no surgery
- AZFc → micro-TESE + ICSI possible
- Genetic counseling is essential before treatment